• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-4/A filed by Environmental Impact Acquisition Corp. (Amendment)

    1/10/22 5:31:37 PM ET
    $ENVI
    Get the next $ENVI alert in real time by email

    Unavailable

    Get the next $ENVI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENVI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ENVI
    SEC Filings

    See more
    • SEC Form 425 filed by Environmental Impact Acquisition Corp.

      425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

      2/2/22 8:34:52 AM ET
      $ENVI
    • Environmental Impact Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Environmental Impact Acquisition Corp (0001822691) (Filer)

      2/2/22 8:32:05 AM ET
      $ENVI
    • SEC Form 425 filed by Environmental Impact Acquisition Corp.

      425 - Environmental Impact Acquisition Corp (0001822691) (Subject)

      1/28/22 9:10:59 AM ET
      $ENVI

    $ENVI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • GreenLight Biosciences begins trading today as Nasdaq: GRNA on the closing of its business combination with Environmental Impact Acquisition Corp.

      BOSTON, Feb. 3, 2022 /PRNewswire/ -- GreenLight Biosciences ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp. (NASDAQ:ENVI) ("ENVI"), a special purpose acquisition company, yesterday announced the closing of their previously announced business combination. In connection with the closing, the company changed its name to GreenLight Biosciences Holdings, public-benefit corporation, with shares of Class A common stock and public warrants

      2/3/22 10:02:00 AM ET
      $ENVI
    • Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022

      BOSTON, Feb. 2, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ:ENVI), a publicly-traded special purpose acquisition company, announced today that its business combination with Greenlight Biosciences was approved in a shareholder vote held yesterday, with 80.7% of shareholders participating in the vote and 78.6% voting in favor of the combination. Subject to the satisfaction or waiver of the other customary closing conditions, Environmental Impact Acquisition Corp. anticipates closing the business combination today. In connection with the closing, the

      2/2/22 8:58:00 AM ET
      $ENVI
    • GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests

      BOSTON, Jan. 31, 2022 /PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA as a seed treatment to control crop diseases and offer options to farmers looking for innovative solutions. Through the partnership, the two companies will explore synergies between Germains' seed priming and coating technologies and GreenLight's dsRNA expertise and ability to cost-effectively scale manufacturing to protect vegetable crops

      1/31/22 10:40:00 AM ET
      $ENVI

    $ENVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Walker Matthew Alan was granted 14,343,021 shares and bought $15,000,000 worth of shares (1,500,000 units at $10.00)

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:22:17 PM ET
      $ENVI
    • SEC Form 3 filed by new insider Walker Matthew Alan

      3 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:20:21 PM ET
      $ENVI
    • SEC Form 4 filed by Keefe Susan

      4 - GreenLight Biosciences Holdings, PBC (0001822691) (Issuer)

      2/4/22 8:01:51 PM ET
      $ENVI